Virtual Symposium (Expired): New Frontiers in the Prevention and Management of Heart Failure

This activity will address knowledge and competency gaps surrounding heart failure (HF) prevention and management with a didactic presentation outlining the risk of HF in patients with cardiometabolic disease in order for HCPs to identify patients who may benefit from screening and if necessary the early initiation of HF treatment. Experts will explain the underlying genetic causes for racial disparities in HF and how biomarkers can assist physicians in predicting survival rates. Expert faculty will also review the 2013 ACCF/AHA guidelines to facilitate the appropriate use of guideline-directed pharmacotherapy recommendations in clinical practice. Additionally, this activity will provide an overview of the different therapeutic classes of agents used to treat heart failure including recently approved therapies. Patient cases will also be presented to help clinicians differentiate and select among the various available treatment options.

Opening Remarks; Prevention of HF as an Urgent Public Health Need

Faculty: Clyde W. Yancy, MD, MSc, MACP

Risk of HF: Special Patient Populations

Faculty: Keith C. Ferdinand, MD, FACC, FAHA

Managing HF, in Cardiometabolic Patients: Guidelines and Treatments

Faculty: Javed Butler, MD, MPH, MBA

Patient Cases and Audience Q&A

Presenter: All Faculty